Viewing Study NCT05808608


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-31 @ 9:27 PM
Study NCT ID: NCT05808608
Status: RECRUITING
Last Update Posted: 2025-01-27
First Post: 2023-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Sponsor: Hao Zeng
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None First-line Treatment View
None Non Clear Cell Renal Cell Carcinoma View
None Sarcomatoid Renal Cell Carcinoma View
Keywords: